Oct 17 (Reuters) - U.S. orthopedic implant maker StrykerCorp on Thursday said quarterly net profit fell 70percent as charges for recalled products offset higher sales ofits hip, knee and spine products.
The company reported a third-quarter net profit of $103million, or 27 cents per share. Net sales for the quarter roseto $2.15 billion from $2.05 billion a year earlier.
Excluding items such as recall and restructuring charges,Stryker earned 98 cents per share. Wall Street analysts, onaverage, expected 99 cents per share, according to ThomsonReuters I/B/E/S.
For the full year, the company said it still expects aprofit in the range of $4.20 to $4.26 a share.
- Company Earnings
- Health Care Industry